Wednesday, September 28, 2022
News

Betamethasone may improve prostate cancer radiation therapy: Study

   SocialTwist Tell-a-Friend    Print this Page   COMMENT

Washington | August 14, 2022 7:26:57 PM IST
A new study suggests that the common steroid betamethasone could be used to reduce unwanted side effects of radiation treatments for prostate cancer.

The study was published in the journal, 'International Journal of Molecular Sciences'.

The lab study led by Luksana Chaiswing, PhD, assistant professor in the UK College of Medicine's Department of Toxicology and Cancer Biology, is the first to demonstrate that betamethasone protects normal prostate cells from injury induced by radiation therapy while making the cancer cells more susceptible to the treatment.

Prostate cancer is the second leading cause of cancer deaths among men in the U.S. While radiation therapy is important to control the growth of prostate cancer, it presents a significant risk of increasing unwanted side effects, including injury to normal tissues.

"New therapies aimed at protecting against normal tissue injury while also increasing radiation therapy effectiveness are urgently needed," Chaiswing said. "The development of such approaches would have a major impact on prostate cancer control and the quality of life of patients."

The team screened around 700 Food and Drug Administration-approved drugs for properties including protecting non-cancer cells against radiation therapy-induced cytotoxicity, killing prostate cancer cells and increasing hydrogen peroxide levels in both cancer and non-cancer cells.

Betamethasone, a corticosteroid that is approved for the treatment of inflammation and cancer of the hematopoietic system, was one of the top five drugs with all of the desired properties.

Betamethasone increases hydrogen peroxide levels, which activates a protective protein called "RelB" in normal, non-cancerous prostate cells.

"The outcome of this project could lead to a new anticancer regimen that improves the efficacy of radiation therapy by sensitizing c to radiation while simultaneously protecting normal tissue from radiation-induced side effects, which could lead to improved quality of life for cancer survivors," Chaiswing said. (ANI)

 
  LATEST COMMENTS ()
POST YOUR COMMENT
Comments Not Available
 
POST YOUR COMMENT
 
 
TRENDING TOPICS
 
 
CITY NEWS
MORE CITIES
 
 
 
MORE HEALTH NEWS
Torrent Pharma to acquire Curatio for Rs...
Lumpy virus: R'sthan, Punjab and Gujarat...
Study finds how ancient viral genes help...
Lassa virus endemic area could significa...
Study: New technologies can be key to pr...
Protein supplement helps control Type 2 ...
More...
 
INDIA WORLD ASIA
BJP rally to Nabanna: HC asks Bengal gov...
One held in Ahmedabad for helping ISI op...
Abu Salem gets three-year term in fake p...
ED takes action against online gaming ap...
Calcutta HC cautions Bengal Home Secy of...
Pixel 7 Pro spec leaks suggest smartphon...
More...    
 
 Top Stories
FM urges I-T officials to expedite ... 
Lumpy virus: R'sthan, Punjab and Gu... 
Reliance Retail launches fashion & ... 
Uddhav vs Shinde: SC allows EC to d... 
Gopi sir, Mathias had told us that ... 
Over 2 lakh people affected by natu... 
Gopi sir told us to win India Mahar... 
DRDO conducts successful test fligh...